Chou Y.-J.Lee K.-Y.Tsai M.-S.HSIN-YUN SUNCHIEN-CHING HUNG2021-12-012021-12-0120131058-4838https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884922238&doi=10.1093%2fcid%2fcit449&partnerID=40&md5=903e0c3ce99c2f216537947cecbafba9https://scholars.lib.ntu.edu.tw/handle/123456789/588838[SDGs]SDG2[SDGs]SDG3cefalexin; cotrimoxazole; placebo; antibiotic therapy; cellulitis; clinical effectiveness; diabetic patient; human; letter; methicillin resistant Staphylococcus aureus; outpatient care; priority journal; randomized controlled trial (topic); soft tissue infection; treatment response; Anti-Bacterial Agents; Cellulitis; Cephalexin; Humans; Trimethoprim-Sulfamethoxazole Combinationletter10.1093/cid/cit449238217312-s2.0-84884922238